Alpha Tau Medical
Prof. Keisari is one of two co-inventors of the Alpha DaRT technology. He was a Full Professor of the Dept. of Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University, Israel until 2015, and is now Prof. Emeritus. His studies focus on the activation of anti-tumoral immune reactivity through in-situ destruction of solid tumors with DaRT, and developing means to improved eradication of metastases. He has co-authored 89 peer-reviewed scientific papers, and is an editorial board member of 5 journals. Prof. Keisari was a founder and past president of the Israeli Society for Cancer Research.
This person is not in any offices
Alpha Tau Medical
Alpha Tau Medical (https://www.alphatau.com/) focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid cancer tumors. Initially developed at Tel Aviv University, Alpha DaRT was shown to be effective and safe for treating different types of cancer in multiple animal studies. The company is running its first clinical trial in several sites in the EU and is currently commencing clinical trials at over 55 leading cancer centers worldwide.